Abstract 18395: Safety of Continuing Ivabradine Treatment During Hospitalization for Worsening of Heart Failure in the SHIFT Study
BackgroundChronic medical treatment is usually adapted during hospitalizations for worsening heart failure (HWHF). Ivabradine, a heart rate (HR)-slowing agent that inhibits the funny current (If) in the sinus node, when added to standard of care reduced the relative risk of HWHF by 26% in the Systol...
Saved in:
Published in | Circulation (New York, N.Y.) Vol. 132; no. Suppl_3 Suppl 3; p. A18395 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
by the American College of Cardiology Foundation and the American Heart Association, Inc
10.11.2015
|
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!